HNCFX | RERGX | HNCFX / RERGX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 8 years | 15 years | - |
Gain YTD | 9.962 | 8.439 | 118% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 250 | 400,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 310M | 137B | 0% |
Annual Yield % from dividends | 0.83 | 1.84 | 45% |
Returns for 1 year | 22.20 | 16.70 | 133% |
Returns for 3 years | -8.09 | -13.11 | 62% |
Returns for 5 years | 27.02 | 16.88 | 160% |
Returns for 10 years | N/A | 35.90 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FMCVX | 31.83 | 0.40 | +1.27% |
Franklin Mutual Small-Mid Cap Val R6 | |||
FBTAX | 34.43 | 0.36 | +1.06% |
Fidelity Advisor Biotechnology A | |||
RYCKX | 44.33 | 0.25 | +0.57% |
Rydex S&P MidCap 400 Pure Growth C | |||
PLFPX | 29.35 | 0.13 | +0.44% |
Principal Large Cap S&P 500 Index R5 | |||
GWEZX | 33.84 | N/A | N/A |
AMG GW&K Small Cap Core Z |